WPRIM Management System> DCMS> Korean Journal of Nephrology> 1998> 17> 3

Volume: 17 Issue: 3

1. Effects of Chronic Hypokalemia on Renal Expression of Na/K-APTase alpha1 and beta1 Subunit. Page:357—365
2. Nonimmunological Factors Influencing Serum Creatinine on Discharge after Kidney Transplantation. Page:494—502
3. Study on the Factors Affecting the Chronic Renal Allograft Dysfunction. Page:483—493
4. Nonrenal Indications for Continuous Arteriovenous Hemofiltration. Page:476—482
5. Phase III Clinical Trial Evaluating Efficacy and Safety of Recombinant Human Erythropoietin(Epokine(R)) in Hemodialysis Patients. Page:466—475
6. Platelet Activation During Hemodialysis Measured Through Expression of P-selectin. Page:461—465
7. Changes of Endotoxin Concentration in Dialysis Solution During Hemodialysis. Page:453—460
8. Access Recirculation Measurement in Variable Temporary Central Catheters by Low-flow Two-needle Method for CRF. Page:446—452
9. Dietary protein intake(DPI) and Nutritional Indices in Predialysis Patients with Different Stages of Chronic Renal Insufficiency. Page:429—439
10. Localization of HBsAg and Hepatitis B Virus DNA in Renal Tissues from HBsAg Positive Patients with the Membranoproliferative Glomerulonephritis. Page:416—428
11. Lymphocyte Subsets in Patients with Hepatitis B Virus Associated Glomerulonephritis. Page:407—415
12. Analysis of Hypokalemia in Emergency Patients. Page:401—406
13. The Furosemide Effects on Renal Blood Flow of Cats Treated with Indomethacin. Page:391—400
14. The Effect of Erythropoietin on the Production of Endothelin in Human Glomerular and Umbilical Endothelial Cells. Page:383—390
15. Alteration of Insulin-like Growth Factor (IGF)-I and IGF-binding Proteins in Rat with Acute Renal Failure. Page:366—375
16. Rifampin Induced Rapidly Progressive Glomerulonephritis. Page:503—509
17. Unusual Location of the Hemodialysis Catheter in Persistent left Superior Vena Cava in a Patient with Chronic Renal Failure. Page:521—525
18. A Case of Rhabdomyolysis with Acute Renal Failure in the Course of Interferon Therapy for Chronic Active Hepatitis B. Page:510—515